| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/14/2013 | CN101282946B 半胱氨酸蛋白酶抑制剂及它们的治疗应用 Cysteine protease inhibitors and their therapeutic applications |
| 08/13/2013 | US8507748 Method for the production of a single heavy chain antibody |
| 08/13/2013 | US8507536 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/13/2013 | US8507521 Heterocyclic derivatives |
| 08/13/2013 | US8507477 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists |
| 08/13/2013 | US8507476 Substituted arylamide diazepinopyrimidone derivatives |
| 08/13/2013 | US8507475 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/13/2013 | US8507439 Neuroprotective and neurorestorative method and compositions |
| 08/13/2013 | US8506990 Local administration of gallium compositions to treat pain |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | US8506936 Stabilized nicotine chewing gum |
| 08/13/2013 | CA2684563C 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| 08/13/2013 | CA2670892C Substituted diazepan compounds as orexin receptor antagonists |
| 08/13/2013 | CA2619566C 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2606473C Benzisoxazole piperazine compounds and methods of use thereof |
| 08/13/2013 | CA2593140C Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2b (ugt2b) |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/13/2013 | CA2433316C Molecular antigen array |
| 08/08/2013 | WO2013116413A1 Diazabicyclo[3.3.1]nonanes, methods of synthesis, and uses thereof |
| 08/08/2013 | WO2013116325A1 Improving postural stability administering droxidopa |
| 08/08/2013 | WO2013116226A2 Prevention of mild cognitive impairment and eventual alzheimer's disease |
| 08/08/2013 | WO2013116186A1 Brimonidine for treating visual disorders mediated by central visual projections from the eye |
| 08/08/2013 | WO2013116174A1 Mglu 2/3 agonists |
| 08/08/2013 | WO2013115793A1 Iron chelators and uses thereof |
| 08/08/2013 | WO2013115535A1 Novel crystalline acid addition salt of tricyclo derivative compound or hydride thereof, and production method therefor |
| 08/08/2013 | WO2013115534A1 Composition for preventing or treating multiple sclerosis |
| 08/08/2013 | WO2013113774A1 Factor xii inhibitors for the treatment of neurological inflammatory disorders |
| 08/08/2013 | WO2013113107A1 Methods for promoting neuron survival, axonal growth and/or regeneration |
| 08/08/2013 | WO2013083887A8 Novel association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide and an nmda receptor antagonist and the pharmaceutical compositions which contain said association |
| 08/08/2013 | WO2012176061A8 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130202722 Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof |
| 08/08/2013 | US20130202689 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| 08/08/2013 | US20130202572 Caffeine-free dietary supplements for increasing energy and methods of administering the same |
| 08/08/2013 | US20130202570 Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof |
| 08/08/2013 | US20130199922 Controlling Chemical Reactions by Spectral Chemistry and Spectral Conditioning |
| 08/07/2013 | EP2623504A1 5,6-Disubstituted oxindole derivatives and their use in the manufacture of a medicament for the treatment of vasopressin-dependent diseases |
| 08/07/2013 | EP2623503A1 Chromene derivatives |
| 08/07/2013 | EP2623499A1 1,2,4-triazolone derivative |
| 08/07/2013 | EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 08/07/2013 | EP2623110A1 Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| 08/07/2013 | EP2623103A1 Patch |
| 08/07/2013 | EP2623099A1 Composition and method for treating neurological disease |
| 08/07/2013 | EP2621945A2 Nd2 peptides and methods of treating neurological disease |
| 08/07/2013 | EP2621926A2 Pyrazolopyrimidine pde10 inhibitors |
| 08/07/2013 | EP2621914A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 08/07/2013 | EP2621906A1 Diazaridine derivatives for treating metal disorders |
| 08/07/2013 | EP2621902A2 3-azabicyclo [3.1.0] hexane compounds useful for the treatment of cns disorders |
| 08/07/2013 | EP2621899A2 Novel methylcyclohexane derivatives and uses thereof |
| 08/07/2013 | EP2621891A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same |
| 08/07/2013 | EP2621512A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/07/2013 | EP2621503A1 Use of a food product comprising viscous fibres which has a beneficial effect on cognitive performance. |
| 08/07/2013 | CN103237803A Triazolopyridine compounds |
| 08/07/2013 | CN103237802A 2-(R2-thio)-10-3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine for treating a beta-amyloidopathy or an alpha-synucleopathy, and method for the diagnosis or prediagnosis thereof |
| 08/07/2013 | CN103237794A P2X4 receptor antagonist |
| 08/07/2013 | CN103237790A Novel methylcyclohexane derivatives and uses thereof |
| 08/07/2013 | CN103237788A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 08/07/2013 | CN103237556A Composition for preventing or treating dementia containing Prunus mume extract |
| 08/07/2013 | CN103237551A Pharmaceutical formulation having neuroprotective activity |
| 08/07/2013 | CN103237547A Crystalline naloxol-eg conjugate |
| 08/07/2013 | CN103232931A Vitamin, microelement and pine pee series health-care snake medicinal liquor for prolonging life |
| 08/07/2013 | CN103232914A Blood-enriching heart-nourishing wine and preparation method thereof |
| 08/07/2013 | CN103232540A Domain antibody construct |
| 08/07/2013 | CN103232474A Histone deacetylase inhibitors |
| 08/07/2013 | CN103232467A Kukoline structurally-reconstructed compound and preparation method thereof |
| 08/07/2013 | CN103232454A Medicine for treating mental disease |
| 08/07/2013 | CN103232350A Acylated Danshensu derivative and application thereof to preventing and treating cerebrovascular and liver and kidney diseases |
| 08/07/2013 | CN103230595A Composition for treating mental diseases |
| 08/07/2013 | CN103230590A Interleukin-1 conjugates and uses thereof |
| 08/07/2013 | CN103230589A Fibrinogen compound and application thereof |
| 08/07/2013 | CN103230588A Application of cholinesterase capable of hydrolyzing P substance at C terminal in preparation of tachykinin antagonist |
| 08/07/2013 | CN103230581A Composition and method for treating traumatic brain injury |
| 08/07/2013 | CN103230571A Sleepiness-eliminating and refreshing preparation and preparation method thereof |
| 08/07/2013 | CN103230554A Compound hovenia dulcis thunb alcoholism-relieving effervescent tablet |
| 08/07/2013 | CN103230539A Bone-disease-treating formula researched and improved on a hereditary basis, and preparation method thereof |
| 08/07/2013 | CN103230538A Fresh dendrobium officinale American ginseng particle and preparation method thereof |
| 08/07/2013 | CN103230485A Medicine for treating Parkinson's disease and preparation method thereof |
| 08/07/2013 | CN103230460A Medicine for treating manic-depressive psychosis and preparation method thereof |
| 08/07/2013 | CN103230433A Yixinbadiranjibuya granule and preparation method thereof |
| 08/07/2013 | CN103230426A Medical composition for treating diabetes mellitus and complications thereof |
| 08/07/2013 | CN103230415A Muscle derived cells (MDCs) for promoting and enhancing nerve repair and regeneration |
| 08/07/2013 | CN103230408A Method for preparing phloretin |
| 08/07/2013 | CN103230389A Novel nitrocatechol derivatives having selectin ligand activity |
| 08/07/2013 | CN103230381A Zolpidem tartrate time-selecting pulse sustained-release pellet and preparation method thereof |
| 08/07/2013 | CN103230380A Divalproex sodium enteric-coated tablet core as well as preparation method and application thereof |
| 08/07/2013 | CN103230368A Statin medicine preparation method |
| 08/07/2013 | CN103230348A Yao drug bath lotion and preparation method thereof |
| 08/07/2013 | CN102727741B Medicament for treating anxiety disorder |
| 08/07/2013 | CN102657783B Drug for treating involutional psychosis |
| 08/07/2013 | CN102657635B Spongy asenapine sublingual film agent with micropores and preparation method thereof |
| 08/07/2013 | CN102626503B Chinese medicinal oral liquid for smoothing heart and enhancing intelligence |
| 08/07/2013 | CN102552456B Medicament for treating anxiety neurosis |
| 08/07/2013 | CN102525921B 2,2',6,6'-tetraisopropyl-4,4'-bigeminy phenol lipid microsphere preparation and preparation method thereof |
| 08/07/2013 | CN102505034B Method for preparing active polypeptide from corn protein powder |
| 08/07/2013 | CN102475700B Daidzein concentrated solution and special diluent agent thereof |
| 08/07/2013 | CN102429906B Use of nitrogen heterocyclic compound in preparing drug for inhibiting toxicity of amyloid polypeptide |
| 08/07/2013 | CN102358721B More stable aceglutamide compound and medicinal composition thereof |
| 08/07/2013 | CN102341091B Riluzole aqueous suspensions |
| 08/07/2013 | CN102302554B Extraction method of schisandra total lignans |
| 08/07/2013 | CN102266472B Chinese medicinal composition for preventing and/or treating diabetic nephropathy and preparation method thereof |